Sideroblastic anemia due to linezolid in a patient with a left ventricular assist device

Journal of Heart and Lung Transplantation

Volumn 23, Issue 9, 2004, Pages 1119-1122

  Montpetit, Michelle C ^a   Shammo, Jamile L ^a   Loew, Jerome ^a   Dunlap, Stephanie ^a   Pamboukian, Salpy V ^a   Heroux, Alain ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LINEZOLID; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CASE REPORT; DEVICE INFECTION; DISEASE SEVERITY; DRUG ERUPTION; DRUG WITHDRAWAL; GRAM POSITIVE BACTERIUM; HEART ASSIST DEVICE; HEART TRANSPLANTATION; HUMAN; INTERSTITIAL NEPHRITIS; MALE; ORTHOTOPIC TRANSPLANTATION; PAPULE; PRIORITY JOURNAL; RECURRENT DISEASE; SIDEROBLASTIC ANEMIA; TREATMENT OUTCOME;

ACETAMIDES; ANEMIA, SIDEROBLASTIC; ANTI-INFECTIVE AGENTS; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; OXAZOLIDINONES; PROSTHESIS-RELATED INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; WAITING LISTS;

EID: 5144228188     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2003.07.028     Document Type: Article

References (17)

1. Abena P.A., Mathieux V.G., Scheiff J.M., Michaux L.M., Vandercam B.C. Linezolid and reversible myelosuppression. JAMA. 286:(16):2001;1291
2. Alcindor T., Bridges K.R. Sideroblastic anemias. Br J Hematol. 116:(4-II):2002;733-743
3. Bottomley S.S. Sideroblastic anemia. Jacobs A., Worwood M. Iron in biochemistry and medicine II. 1980;363 Academic Press, London
4. Rudek M.A., Horne M., Figg W.D., et al. Reversible sideroblastic anemia associated with the tetracycline analogue COL-3. Am J Hematol. 67:2001;51-53
5. Brodsky R.A., Hasegawa S., Fibach E., Dunbar C.E., Young N.S., Rodgers G.P. Acquired sideroblastic anemia following progesterone therapy. Br J Hematol. 87:(4):1994;859-862
6. Murakami R., Takumi T., Gouji J., Nakamura H., Kondou M. Sideroblastic anemia showing unique response to pyridoxine. Am J Pediatr Hematol. 13:1991;345-350
7. Negrin R.S., Stein R., Doherty K., et al. Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin evidence for in vivo synergy. Blood. 87:1996;4076-4081
8. Hellstrom-Lindberg E., Ahlgen T., Beguin Y., et al. Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin Results from a randomized phase II study and long-term follow-up of 71 patients. Blood. 92:1998;68-75
9. Kuter D.J., Tillotson G.S. Hematologic effects of antimicrobials focus on the oxazolidinone linezolid. Pharmacotherapy. 21:(8):2001;1010-1013
10. Green S.L., Maddox J.C., Huttenbach E.D. Linezolid and reversible myelosuppression. JAMA. 285:(10):2001;1291
11. Green S.L., Maddox J.C. Linezolid and reversible myelosuppression. JAMA. 286:(16):2001;1975
12. Linezolid (Zyvox). The Medical Letter. 42:2000;45-46
13. Gerson S.L., Kaplan S.L., Bruss J.B., et al. Hematologic effects of linezolid Summary of clinical experience. Antimicrob Agents Chemother. 46:(8):2002;2723-2726
14. Waldrep T.W., Siest D.J. Linezolid-induced anemia and thrombocytopenia. Pharmacotherapy. 22:(1):2002;109-112
15. Lawyer M.C., Lawyer E.Z. Linezolid and reversible myelosuppression. JAMA. 286:(16):2001;1292
16. Jimenez J.J., Arimura G.K., Abou-Khalil W.H., Isildar M., Yunis A.A. Chloramphenicol-induced bone marrow injury possible role of bacterial metabolites of chloramphenicol. Blood. 70:1987;1180-1185
17. Itescu S., Ankermit J.H., Kocher A.A., Schuster M.D. Immunobiology of left ventricular assist devices. Progr Cardiovasc Dis. 43:(1):2000;67-80